Table 2 Distribution of iNOS scores of tumor cells (iNOS-T), tumor-associated stromal fibroblasts (iNOS-F), and endothelial cells (iNOS-E) according to clinicopathologic parameters in cases with gastric carcinoma

Histological type

NOS/tubular/papillary

2.6 ± 2.3 (0–6)

4.8 ± 1.7 (2–8)

5.9 ± 2.1 (2–8)

Mucinous/poorly cohesive

4.8 ± 2.2 (2–8)

4.4 ± 1.9 (2–7)

5.9 ± 2.7 (2–8)

Differentiation

Well/moderate

2.6 ± 2.3 (0–6)

4.6 ± 2.2 (0–8)

5.6 ± 2.8 (2–8)

Poorly/signet ring cell

4.8 ± 2.2 (2–8)

4.3 ± 1.3 (0–8)

6.0 ± 1.6 (2–8)

pN

N0

1.3 ± 1.8 (0–5)

2.9 ± 1.3 (2–5)

3.2 ± 1.9 (2–7)

N1

4.1 ± 1.3 (2–6)

5.9 ± 1.6 (4–8)

6.7 ± 1.7 (4–8)

N2

4.1 ± 1.9 (2–8)

4.9 ± 1.2 (3–7)

6.6 ± 1.3 (4–8)

N3

5.9 ± 2.2 (2–8)

5.2 ± 1.2 (3–7)

6.6 ± 1.1 (4–8)

pT

T1

1.5 ± 1.1 (0–7)

2.4 ± 1.2 (2–7)

3.1 ± 1.7 (2–7)

T2

4.2 ± 1.5 (2–6)

5.4 ± 1.7 (4–8)

6.8 ± 1.8 (4–8)

T3

4.4 ± 1.9 (2–8)

4.9 ± 1.5 (3–7)

6.2 ± 1.7 (4–8)

T4

5.9 ± 2.1 (2–8)

5.1 ± 1.4 (3–7)

6.9 ± 1.2 (4–8)

TNM stage

I

0.0 ± 0.0 (0–0)

3.3 ± 1.5 (2–5)

4.0 ± 2.6 (2–7)

II

3.2 ± 1.8 (0–6)

4.4 ± 1.9 (2–8)

5.0 ± 2.4 (2–8)

III

5.4 ± 3.2 (2–8)

5.3 ± 1.3 (3–7)

6.8 ± 1.0 (4–8)

IV

-

-

-

Total

4.0 ± 2.5 (0–8)

4.0 ± 2.5 (0–8)

5.9 ± 2.0 (2–8)